NIH-funded research NIH-funded research

Promoting regenerative healing for chronic wounds

Official title: Defining translational mechanisms to promote regenerative healing of chronic wounds

Funded at VA Connecticut Healthcare System · NIH-11212824 · Data updated 2026-11-12

Using new knowledge about skin cells and signals to help older adults and people with diabetes heal chronic wounds more fully and durably.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVA Connecticut Healthcare System
NIH-funded
Lab location1 site (West Haven, United States)
Project startOctober 1, 2021
Project endSeptember 30, 2026
Funding year2026
NIH project number5I01BX005299-05
Project IDNIH-11212824 on NIH RePORTER

Who could benefit from this research

Could help

People with chronic, non-healing skin wounds—especially older adults and patients with diabetes (including veterans)—who are willing to receive care and follow-up at the treating site.

Less likely to help

Patients with normal acute wounds that heal quickly or with wound problems unrelated to impaired skin repair mechanisms may not benefit directly from this work.

What this research studies

This research looks at the different cell types in human skin and how they communicate during wound repair, with a focus on cells like fibroblasts and macrophages. Scientists will use advanced cell-profiling methods (including CITE-seq) and biochemical studies to map the signals that drive healthy versus non-healing wounds. Findings from human tissue and complementary models will be used to identify targets that can be turned into treatments to restore regenerative healing. The long-term aim is to move promising targets toward therapies that reduce chronic wound complications common in older and diabetic patients.

Why it matters

Potential benefit: Could lead to new treatments that encourage durable, regenerative healing of chronic wounds, lowering infection risk and improving quality of life.

How similar studies have gone: Prior animal and lab studies have shown key roles for fibroblast subtypes, macrophages, and cytokines in healing, but translating those findings into human therapies is still largely experimental.

Where this research is happening

  • VA Connecticut Healthcare System
    West Haven, United States
    Active

Researchers

  • Principal investigator: Hsia, Henry C — VA Connecticut Healthcare System
  • Study coordinator: Hsia, Henry C

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.